Opportunities for Overcoming


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jun 2019
Historique:
received: 30 04 2019
revised: 31 05 2019
accepted: 06 06 2019
entrez: 20 6 2019
pubmed: 20 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

The ever-increasing incidence of drug-resistant

Identifiants

pubmed: 31212777
pii: ijms20122868
doi: 10.3390/ijms20122868
pmc: PMC6627145
pii:
doi:

Substances chimiques

Antitubercular Agents 0
Bacterial Proteins 0
Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : G066619N / 12N5915N / 1S31316N

Références

Mol Microbiol. 1999 Mar;31(5):1573-87
pubmed: 10200974
Curr Opin Microbiol. 1999 Oct;2(5):504-8
pubmed: 10508721
Biochemistry. 1999 Sep 7;38(36):11827-33
pubmed: 10512639
Nature. 2000 Jun 22;405(6789):962-6
pubmed: 10879539
Microbiol Mol Biol Rev. 2000 Dec;64(4):672-93
pubmed: 11104814
Biochemistry. 2001 May 1;40(17):5119-26
pubmed: 11318633
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12712-7
pubmed: 11606763
Clin Microbiol Rev. 2002 Apr;15(2):294-309
pubmed: 11932234
J Bacteriol. 2002 Jun;184(12):3287-95
pubmed: 12029045
Chem Biol. 2002 May;9(5):545-53
pubmed: 12031661
J Comb Chem. 2003 Mar-Apr;5(2):172-87
pubmed: 12625709
Mol Microbiol. 2003 Apr;48(1):77-84
pubmed: 12657046
Cell. 2003 Apr 18;113(2):183-93
pubmed: 12705867
Nat Struct Mol Biol. 2004 Feb;11(2):135-41
pubmed: 14730350
Annu Rev Physiol. 2004;66:689-733
pubmed: 14977419
AIDS. 2004 Jan 23;18(2):257-64
pubmed: 15075543
J Clin Immunol. 2004 May;24(3):249-57
pubmed: 15114055
Nat Genet. 2004 Jun;36(6):585-95
pubmed: 15146184
IUBMB Life. 2004 Mar;56(3):131-8
pubmed: 15185746
Science. 2005 Jan 14;307(5707):223-7
pubmed: 15591164
Br J Pharmacol. 2005 Jan;144(1):80-7
pubmed: 15644871
Chem Rev. 2005 Feb;105(2):621-32
pubmed: 15700959
Infect Immun. 2005 Jun;73(6):3492-501
pubmed: 15908378
Antimicrob Agents Chemother. 2005 Jun;49(6):2289-93
pubmed: 15917523
J Antimicrob Chemother. 2005 Nov;56(5):968-74
pubmed: 16172107
J Bacteriol. 2005 Dec;187(23):8020-5
pubmed: 16291675
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):431-6
pubmed: 16387854
Br J Pharmacol. 2006 Mar;147(5):476-85
pubmed: 16432511
Science. 2006 Mar 24;311(5768):1770-3
pubmed: 16497887
PLoS Med. 2006 Nov;3(11):e466
pubmed: 17132069
J Antimicrob Chemother. 2007 Feb;59(2):313-6
pubmed: 17185297
Antimicrob Agents Chemother. 2007 Apr;51(4):1563-5
pubmed: 17242141
Nat Chem Biol. 2007 Jun;3(6):323-4
pubmed: 17496888
Int J Antimicrob Agents. 2007 Oct;30(4):336-40
pubmed: 17644321
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
pubmed: 17717517
Biochem Biophys Res Commun. 2007 Nov 9;363(1):71-6
pubmed: 17826740
Bioorg Med Chem. 2007 Dec 15;15(24):7638-46
pubmed: 17888665
Annu Rev Microbiol. 2007;61:35-50
pubmed: 18035606
Infect Immun. 2008 Mar;76(3):916-26
pubmed: 18212087
Cell Host Microbe. 2008 Apr 17;3(4):224-32
pubmed: 18407066
Microbiol Mol Biol Rev. 2008 Sep;72(3):471-94
pubmed: 18772286
J Exp Med. 2008 Nov 24;205(12):2791-801
pubmed: 18955568
Biochim Biophys Acta. 2009 May;1794(5):769-81
pubmed: 19026770
Cytokine. 2009 Feb;45(2):105-10
pubmed: 19091593
Science. 2009 May 8;324(5928):801-4
pubmed: 19299584
Biochemistry. 2009 Aug 4;48(30):7150-9
pubmed: 19505149
J Immunol. 2009 Aug 1;183(3):2089-96
pubmed: 19597002
Cell Host Microbe. 2009 Sep 17;6(3):231-43
pubmed: 19748465
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13093-8
pubmed: 20615954
J Am Chem Soc. 2010 Oct 6;132(39):13663-5
pubmed: 20828197
Antimicrob Agents Chemother. 2011 Feb;55(2):567-74
pubmed: 21078950
Tuberculosis (Edinb). 2011 Mar;91(2):111-6
pubmed: 21216669
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5051-6
pubmed: 21383189
Clin Vaccine Immunol. 2011 Jun;18(6):907-13
pubmed: 21471301
J Biol Chem. 2011 Sep 16;286(37):32475-82
pubmed: 21813647
Int J Mass Spectrom. 2011 Aug 15;305(2-3):151-156
pubmed: 21857792
Expert Rev Clin Pharmacol. 2011 Sep;4(5):583-91
pubmed: 22046197
Expert Rev Mol Med. 2011 Dec 16;13:e39
pubmed: 22172201
Eur J Med Chem. 2012 Feb;48:57-68
pubmed: 22182928
J Am Chem Soc. 2012 Jan 18;134(2):912-5
pubmed: 22188377
Antimicrob Agents Chemother. 2012 Apr;56(4):1797-809
pubmed: 22252828
Cell. 2012 Feb 3;148(3):434-46
pubmed: 22304914
PLoS One. 2012;7(6):e39680
pubmed: 22761866
Cytokine. 2012 Oct;60(1):212-9
pubmed: 22800603
Antimicrob Agents Chemother. 2013 Jan;57(1):168-76
pubmed: 23089752
J Infect Dis. 2013 Jul 15;208(2):199-202
pubmed: 23564636
Am J Clin Exp Immunol. 2013 Feb 27;2(1):124-34
pubmed: 23885330
Nat Med. 2013 Sep;19(9):1157-60
pubmed: 23913123
J Med Chem. 2013 Dec 12;56(23):9701-8
pubmed: 24215368
ACS Med Chem Lett. 2013 Dec 12;4(12):1233-1237
pubmed: 24478820
EMBO Mol Med. 2014 Mar;6(3):372-83
pubmed: 24500695
Biochim Biophys Acta. 2014 Jul;1837(7):1208-18
pubmed: 24513197
J Med Chem. 2014 Apr 10;57(7):3126-39
pubmed: 24568559
PLoS Pathog. 2014 Feb 20;10(2):e1003946
pubmed: 24586159
J Med Chem. 2014 Apr 10;57(7):2895-907
pubmed: 24611928
J Med Chem. 2014 Jun 12;57(11):4487-97
pubmed: 24694071
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2508-11
pubmed: 24767848
J Med Chem. 2014 Jun 26;57(12):5293-305
pubmed: 24870926
J Med Chem. 2014 Jul 10;57(13):5728-37
pubmed: 24874895
J Antibiot (Tokyo). 2014 Dec;67(12):835-7
pubmed: 24916895
Antimicrob Agents Chemother. 2014 Sep;58(9):5325-31
pubmed: 24957839
Antimicrob Agents Chemother. 2014 Nov;58(11):6413-23
pubmed: 25136022
Int Immunopharmacol. 2014 Nov;23(1):148-52
pubmed: 25194676
Nature. 2015 Jan 29;517(7536):612-5
pubmed: 25470057
Antimicrob Agents Chemother. 2015 Mar;59(3):1455-65
pubmed: 25534737
EMBO Mol Med. 2014 Dec 22;7(2):127-39
pubmed: 25535254
DNA Cell Biol. 2015 Apr;34(4):228-42
pubmed: 25607549
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1827-32
pubmed: 25624495
J Antimicrob Chemother. 2015 Jul;70(7):2028-37
pubmed: 25754998
Nat Rev Immunol. 2015 Apr;15(4):255-63
pubmed: 25765201
PLoS One. 2015 Mar 26;10(3):e0119760
pubmed: 25811866
J Antimicrob Chemother. 2015 Aug;70(8):2287-94
pubmed: 25957580
Antimicrob Agents Chemother. 2015 Sep;59(9):5316-23
pubmed: 26100695
Microbiol Mol Biol Rev. 2016 Jan 13;80(1):139-60
pubmed: 26764017
Lancet Glob Health. 2016 Feb;4(2):e89-90
pubmed: 26823222
Bioorg Med Chem Lett. 2016 May 1;26(9):2278-83
pubmed: 27013391
Adv Microb Physiol. 2016;68:219-352
pubmed: 27134025
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5198-207
pubmed: 27297488
Sci Rep. 2016 Jul 07;6:29491
pubmed: 27383057
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6271-80
pubmed: 27503647
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6977-6979
pubmed: 27620476
Clin Microbiol Infect. 2017 Mar;23(3):141-146
pubmed: 27665703
J Med Chem. 2017 Feb 23;60(4):1379-1399
pubmed: 28075132
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167545
Antimicrob Agents Chemother. 1989 Sep;33(9):1493-9
pubmed: 2817850
FEMS Microbiol Rev. 2017 May 1;41(3):354-373
pubmed: 28369307
Mol Cell. 2017 Apr 20;66(2):169-179.e8
pubmed: 28392175
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):624-637
pubmed: 28482956
Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L218-L229
pubmed: 28495854
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4492-E4500
pubmed: 28507124
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28674049
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807917
Nat Rev Drug Discov. 2018 Jan;17(1):35-56
pubmed: 28935918
J Med Chem. 2017 Oct 12;60(19):8011-8026
pubmed: 28953378
Front Med (Lausanne). 2017 Oct 18;4:171
pubmed: 29094039
J Membr Biol. 2018 Feb;251(1):105-117
pubmed: 29098330
Carbohydr Res. 2017 Dec 1;453-454:10-18
pubmed: 29107814
Clin Infect Dis. 2018 May 2;66(10):1625-1630
pubmed: 29126225
ChemMedChem. 2018 Mar 6;13(5):422-430
pubmed: 29334428
Pathogens. 2018 Feb 23;7(1):null
pubmed: 29473841
Tuberculosis (Edinb). 2018 Jan;108:186-194
pubmed: 29523322
Nature. 1987 Jun 4-10;327(6121):389-94
pubmed: 2953976
Mol Microbiol. 2018 Jun;108(6):627-640
pubmed: 29575247
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29784848
Pathog Dis. 2018 Jun 1;76(4):
pubmed: 29788125
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29844043
Nucleic Acids Res. 2018 Aug 21;46(14):6950-6961
pubmed: 29947784
Front Microbiol. 2018 Jul 03;9:1367
pubmed: 30018597
Chemotherapy. 2018;63(3):172-180
pubmed: 30032143
Sci Rep. 2018 Aug 23;8(1):12664
pubmed: 30140040
MBio. 2018 Oct 9;9(5):
pubmed: 30301850
Virulence. 2019 Dec;10(1):448-459
pubmed: 30322337
Tuberculosis (Edinb). 2018 Dec;113:43-54
pubmed: 30514513
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782992
Mol Cell. 2019 Mar 21;73(6):1282-1291.e8
pubmed: 30792174
Org Biomol Chem. 2019 Mar 13;17(11):2923-2939
pubmed: 30801604
Bioorg Med Chem. 2019 Apr 1;27(7):1292-1307
pubmed: 30803745
Microbiol Rev. 1996 Dec;60(4):575-608
pubmed: 8987357
Science. 1997 May 30;276(5317):1420-2
pubmed: 9162010
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
Prog Lipid Res. 1998 Jul-Aug;37(2-3):143-79
pubmed: 9829124
Front Biosci. 1998 Dec 15;3:D1253-61
pubmed: 9851911

Auteurs

Eveline Torfs (E)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk (Antwerpen), Belgium. eveline.torfs@uantwerpen.be.

Tatiana Piller (T)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk (Antwerpen), Belgium. tatiana.piller@uantwerpen.be.

Paul Cos (P)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk (Antwerpen), Belgium. paul.cos@uantwerpen.be.

Davie Cappoen (D)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk (Antwerpen), Belgium. davie.cappoen@uantwerpen.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH